tiprankstipranks
Dianthus Therapeutics (DE:87E)
FRANKFURT:87E
Germany Market
87E
Dianthus Therapeutics
RESEARCH TOOLSreports

Dianthus Therapeutics (87E) Ratios

0 Followers

Dianthus Therapeutics Ratios

DE:87E's free cash flow for Q1 2026 was $0.84. For the 2026 fiscal year, DE:87E's free cash flow was decreased by $ and operating cash flow was $-100.50. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 29.25 13.32 15.22 18.42 9.97
Quick Ratio
 29.25 13.32 15.22 18.42 9.97
Cash Ratio
 16.40 1.66 1.24 13.74 1.87
Solvency Ratio
 -0.24 -4.33 -3.93 -4.10 -3.00
Operating Cash Flow Ratio
 -3.40 -4.20 -4.24 -3.83 -3.53
Short-Term Operating Cash Flow Coverage
 -326.53 -351.66 -244.31 0.00 0.00
Net Current Asset Value
$ 1.07B$ 371.92M$ 259.37M$ 166.92M$ 72.58M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 <0.01 0.01
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 <0.01 0.01
Long-Term Debt-to-Capital Ratio
 <0.01 <0.01 0.00 0.00 0.00
Financial Leverage Ratio
 1.04 1.08 1.06 1.06 1.13
Debt Service Coverage Ratio
 -469.63 -484.83 -317.04 0.00 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 <0.01 <0.01 <0.01 0.00 0.00
Interest Debt Per Share
 0.03 0.04 0.04 0.11 0.21
Net Debt to EBITDA
 3.34 0.28 0.21 2.75 0.49
Profitability Margins
Gross Profit Margin
94.31%100.00%100.00%100.00%100.00%
EBIT Margin
-14054.34%-8739.34%-1633.74%-1704.67%-462.91%
EBITDA Margin
-14025.52%-8739.34%-1627.14%-1692.11%-460.62%
Operating Profit Margin
-14318.04%-8739.34%-1633.74%-1704.67%-462.91%
Pretax Profit Margin
-847.53%-7973.33%-1362.77%-1541.22%-443.76%
Net Profit Margin
-847.53%-7973.33%-1362.77%-1541.22%-443.76%
Continuous Operations Profit Margin
-847.53%-7973.33%-1362.77%-1541.22%-443.76%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
5.92%91.23%83.41%90.41%95.86%
Return on Assets (ROA)
-0.91%-30.58%-22.72%-24.28%-34.26%
Return on Equity (ROE)
-1.78%-32.90%-24.11%-25.79%-38.66%
Return on Capital Employed (ROCE)
-15.83%-35.57%-28.65%-28.38%-39.67%
Return on Invested Capital (ROIC)
-15.82%-35.55%-28.62%-28.31%-39.48%
Return on Tangible Assets
-0.91%-30.58%-22.72%-24.28%-34.26%
Earnings Yield
-0.25%-10.42%-11.70%-81.27%-120.24%
Efficiency Ratios
Receivables Turnover
 1.02 19.96 7.73 5.91 1.14
Payables Turnover
 0.01 0.00 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.85 1.25 3.57 3.53 6.71
Asset Turnover
 <0.01 <0.01 0.02 0.02 0.08
Working Capital Turnover Ratio
 <0.01 <0.01 0.03 0.02 0.05
Cash Conversion Cycle
 -24.97K 18.29 47.24 61.74 320.69
Days of Sales Outstanding
 358.72 18.29 47.24 61.74 320.69
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 25.33K 0.00 0.00 0.00 0.00
Operating Cycle
 358.72 18.29 47.24 61.74 320.69
Cash Flow Ratios
Operating Cash Flow Per Share
 -2.71 -3.41 -2.35 -7.15 -7.76
Free Cash Flow Per Share
 -2.72 -3.42 -2.35 -7.17 -7.79
CapEx Per Share
 <0.01 <0.01 <0.01 0.02 0.04
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -654.70 -605.92 -744.57 -335.10 -209.14
Capital Expenditure Coverage Ratio
 -654.70 -605.92 -744.57 -335.10 -209.14
Operating Cash Flow Coverage Ratio
 -95.52 -93.12 -52.43 -63.01 -36.89
Operating Cash Flow to Sales Ratio
 -97.52 -63.39 -12.54 -13.04 -4.53
Free Cash Flow Yield
-3.36%-8.30%-10.78%-68.98%-123.34%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -341.53 -9.59 -8.55 -1.23 -0.83
Price-to-Sales (P/S) Ratio
 2.52K 764.98 116.48 18.97 3.69
Price-to-Book (P/B) Ratio
 3.22 3.16 2.06 0.32 0.32
Price-to-Free Cash Flow (P/FCF) Ratio
 -25.76 -12.05 -9.28 -1.45 -0.81
Price-to-Operating Cash Flow Ratio
 -29.68 -12.07 -9.29 -1.45 -0.81
Price-to-Earnings Growth (PEG) Ratio
 -5.04K -0.15 0.12 -0.11 >-0.01
Price-to-Fair Value
 3.22 3.16 2.06 0.32 0.32
Enterprise Value Multiple
 -14.60 -8.47 -6.95 1.63 -0.31
Enterprise Value
 3.26B 1.51B 704.94M -78.14M 9.11M
EV to EBITDA
 -17.38 -8.47 -6.95 1.63 -0.31
EV to Sales
 2.44K 740.57 113.06 -27.65 1.42
EV to Free Cash Flow
 -24.96 -11.66 -9.00 2.11 -0.31
EV to Operating Cash Flow
 -25.00 -11.68 -9.02 2.12 -0.31
Tangible Book Value Per Share
 25.01 13.05 10.58 32.77 19.66
Shareholders’ Equity Per Share
 25.01 13.05 10.58 32.77 19.66
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.03 0.05 0.19 0.55 1.71
Net Income Per Share
 -0.24 -4.30 -2.55 -8.45 -7.60
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 0.06 0.91 0.83 0.90 0.96
Research & Development to Revenue
 114.64 71.53 13.33 11.62 4.58
SG&A to Revenue
 29.54 16.86 4.01 6.43 1.05
Stock-Based Compensation to Revenue
 21.02 11.19 2.07 1.03 0.24
Income Quality
 0.75 0.80 0.92 0.85 1.02
Currency in USD